Editors' ChoiceCancer

Coaxing cancer control by modulating COX-2

See allHide authors and affiliations

Science Translational Medicine  19 Jun 2019:
Vol. 11, Issue 497, eaax9566
DOI: 10.1126/scitranslmed.aax9566

Abstract

Mouse models of pancreatic ductal adenocarcinoma respond to immunotherapy when given in combination with the cyclooxygenase-2 inhibitor celecoxib.

View Full Text